Phase 1 study of the PI3Kd inhibitor INCB040093 6 JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma

Tycel J. Phillips, Andres Forero-Torres, Taimur Sher, Catherine S. Diefenbach, Patrick Johnston, Moshe Talpaz, Jennifer Pulini, Li Zhou, Peggy Scherle, Xuejun Chen, Paul M. Barr

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint Dive into the research topics of 'Phase 1 study of the PI3Kd inhibitor INCB040093 6 JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds